C

CyanVac LLC

14 employees

Cyanvac develops vaccines using a proprietary transformational parainfluenza virus 5 (PIV5)-based vector.

Basic info

Industry

biotechnology research

Sectors

Biotechnology

Pharmaceutical

Medical

Health Care

Manufacturing

Date founded

2017

FAQ